Breast fine‐needle aspiration samples reported as “proliferative breast lesion”: Clinical utility of the subcategory “proliferative breast lesion with atypia”
Authors:
Open Access
- 20 February 2009
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 117 (2) , 137-147
Abstract
BACKGROUND: The fine‐needle aspiration (FNA) diagnosis of proliferative breast lesion is an indeterminate category. The aim of this correlative study was to determine whether a subcategory of “proliferative breast lesion with atypia” was achievable and whether this subcategory has management utility.METHODS: Breast FNA cases from 2000 through 2005 diagnosed as proliferative breast lesion and proliferative breast lesion with atypia were retrieved. Both cytologic and surgical slides of these cases were reviewed blindly. A cytologic diagnosis of proliferative breast lesion (without atypia) or proliferative breast lesion with atypia was used if the findings of the proliferative breast lesion did not fit a more specific category.RESULTS: Of the 3934 breast FNAs performed on palpable breast masses from January 2000 to December 2005 at the LAC + USC Medical Center, 317 (8.1%) were diagnosed cytologically as proliferative breast lesion with atypia, without atypia or without mention of atypia. There was subsequent histopathology on 201 of these cases. After the cytologic smears were reviewed, 29 cases were excluded from this study. Of the 172 remaining cases, 21 (12.2%) were found to be malignant and the remaining 151 (87.8%) were found to be benign on histology. Of the malignant cases, 90% had an FNA diagnosis of proliferative breast lesion with atypia; of the benign cases, 78% were interpreted as proliferative breast lesion without atypia.CONCLUSIONS: Proliferative breast lesion with atypia was clinically significant because it was associated with a significantly increased likelihood of malignancy compared with proliferative breast lesion without atypia. Most of the malignancies had hypocellularity or low nuclear grade on the FNA smears. Fibroadenoma accounted for most of the benign lesions in both proliferative breast lesion and proliferative breast lesion with atypia. Cancer (Cancer Cytopathol) 2009. © 2009 American Cancer Society.Keywords
This publication has 29 references indexed in Scilit:
- FNA of breast fibroadenoma: observer variability and review of cytomorphology with cytohistological correlationCytopathology, 2006
- Fine needle aspiration cytology of lobular carcinoma in situ on ThinPrep®Diagnostic Cytopathology, 2005
- The significance of the diagnosis of atypia in breast fine‐needle aspirationDiagnostic Cytopathology, 2004
- Interobserver agreement of a probabilistic approach to reporting breast fine‐needle aspirations on ThinPrep®Diagnostic Cytopathology, 2004
- Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: Results of the Papanicolaou Society of Cytopathology studyDiagnostic Cytopathology, 1998
- Cytologic Features of Ductal and Lobular Carcinoma in Fine Needle Aspirates of the BreastActa Cytologica, 1997
- Is the fine‐needle aspiration biopsy diagnosis of proliferative breast disease feasible?Diagnostic Cytopathology, 1994
- Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosisDiagnostic Cytopathology, 1993
- Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine‐needle aspiratesDiagnostic Cytopathology, 1991
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985